Novel conditioning regimens and nonmyeloablative stem cell transplants

Current Opinion in Pediatrics

Volumn 14, Issue 1, 2002, Pages 17-22

  Baker, K Scott ^a   Wagner, John E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; MORBIDITY; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TOXICITY; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC AGENTS; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHATIC IRRADIATION; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 0036190198     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200202000-00004     Document Type: Review

References (32)

1. Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
2. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
3. Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice
4. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation
5. A nonmyeloablative regimen for induction of multi-lineage hematopoietic mixed donor-host chimerism in non-malignant disorders
6. Successful use of non-myeloablative therapy in the treatment of severe hemoglobinopathies: Proof of principle
7. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens
8. Nonmyeloablative hematopoietic cell transplantation
9. Nonmyeloablative allogeneic stem cell transplantation: Early promise and limitations
10. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
11. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism
12. Regimen related toxicities associated with nonmyeloablative conditioning and postgrafting cyclosporine and mycophenolate mofetil
13. Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation
14. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
15. Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: Results of a pilot study as salvage therapy after autologous transplantation
16. Non-myeloablative allogeneic stem cell transplantation in children
17. Is it time to reduce toxicity by non-myeloablative conditioning for allogeneic stem cell transplantation in children?
18. Bone marrow transplantation without myeloablation for sickle cell disease
19. Superior engraftment in patients with Fanconi anemia (FA) conditioned with fludarabine (flu), cyclophosphamide (CY), total body irradiation (TBI) and antithymocyte globulin (ATG) prior to unrelated donor hematopoietic cell transplantation (HCT)
20. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome
21. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
22. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
23. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft
24. Engraftment of a T-cell depleted matched unrelated donor stem cell graft using non-myeloablative conditioning
25. Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria
26. Stem-cell transplantation for inherited immunodeficiency disorders
27. Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia
28. Bone marrow transplantation for hemoglobinopathies
29. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation
30. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis
31. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease
32. Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT